Articles

In 2017, we offered weekly survey questions on topics ranging from standard tests, to new drugs, to opinions on CGMs, to personal exercise habits - and you answered. Here are the survey questions that drew the most response this year.

Poll finds less than half of health care professionals aware of newest drug up for FDA approval.

How can health care practitioners play a more prominent role in helping patients to take prescribed medications?

The first study to examine overtreatment and deintensification in a Medicare population with diabetes.

Study reports Vitamin D supplementation may improve HbA1c and lower cholesterol.

Comprehensive recommendations feature notable new recommendations for people with cardiovascular disease and diabetes.

Identifying causes of death and related risk factors in patients with type 2 diabetes and cardiovascular disease may help with prevention.

Additive glucose-lowering effect of a dipeptidyl peptidase-4 (DPP4) inhibitor and an alpha-glucosidase inhibitor (AGI) might be beneficial in patients with T2DM.

Once-weekly injectable suspension can provide as much benefit as traditional twice-daily dosing.

New SGLT-2 inhibitor can be used as add-on therapy to provide better improvement in HbA1C in patients with type 2 diabetes.